The new test helps diagnose the correct type of ovarian cancer, which is either benign or malignant. The fine-tune ultrasound test provides accurate diagnosis.

‘Ovarian cancer is a common and potentially lethal disease, which affects approximately 230,000 women globally. Early diagnosis and treatment can improve the outcome for patients.’

Many women with a benign ovarian tumor may need a minimally invasive surgery or no surgery at all. However, women with malignant tumor have to undergo more radical surgery to remove the tumor. Such operation takes much longer and comes with a greater risk of complications.




To increase the patient’s chances of survival, women with malignant tumor should be treated by a gynecological oncologist. Before the surgical intervention, it is important to classify the type of tumor. This new test provides the exact risk of the tumor being benign or malignant, the researchers explained.
This study represented the culmination of multiple consecutive multicenter studies involving 22 centers in 10 countries over 13 years (1999 to 2012) and approximately 5,000 patients.
The study is published in the American Journal of Obstetrics and Gynecology.
Source-Medindia